U.S. LIPOSOMAL DOXORUBICIN MARKET ANALYSIS

U.S. Liposomal Doxorubicin Market, by Drug Type (Branded and Generic), by Cancer Type (Ovarian Cancer, AIDS-related Kaposi’s Sarcoma, Multiple Myeloma, and Others), and by States (California, Texas, Florida, New York, Pennsylvania, Illinois, Ohio, Georgia, North Carolina, Michigan, New Jersey, Virginia, Washington, Arizona, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In : Jul 2021
Code : CMI4508
Pages :148
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Some side effects associated with liposomal doxorubicin drug is expected to hamper the growth of market. The side effects include increased risk of infection, breathlessness and pale complexion, bruising, bleeding gums and nosebleeds, tiredness and weakness (fatigue) during and after treatment, redness, soreness, and peeling of the hands and feet, loss of weight, and diarrhea among others.